Aptose Biosciences Inc (APS.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 22 | 40 | 25 | 25 | 25 |
| Accounts payable and accrued liabilities | N/A | N/A | 13 | N/A | -148 |
| Other Working Capital | 576 | -380 | 288 | 121 | -164 |
| Other Operating Activity | -3,234 | -2,418 | -2,818 | -3,738 | -3,198 |
| Operating Cash Flow | $-2,636 | $-2,757 | $-2,492 | $-3,593 | $-3,484 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 0 | -1 | N/A | 0 | -2 |
| Purchase Of Investment | 0 | N/A | N/A | N/A | -32 |
| Sale Of Investment | N/A | -137 | N/A | 6,404 | N/A |
| Other Investing Activity | 8 | 8 | 9 | 26 | 36 |
| Investing Cash Flow | $8 | $-130 | $9 | $6,430 | $2 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 3,669 | 3,211 | 733 | 1,701 | N/A |
| Financing Cash Flow | $3,669 | $3,211 | $733 | $1,701 | $0 |
| Exchange Rate Effect | -70 | -64 | 38 | -18 | -186 |
| Beginning Cash Position | 7,995 | 7,865 | 9,577 | 5,211 | 8,862 |
| End Cash Position | 8,967 | 7,932 | 7,865 | 9,732 | 5,194 |
| Net Cash Flow | $1,042 | $323 | $-1,750 | $4,539 | $-3,482 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,636 | -2,757 | -2,492 | -3,593 | -3,484 |
| Capital Expenditure | N/A | -1 | N/A | N/A | -2 |
| Free Cash Flow | -2,636 | -2,759 | -2,492 | -3,593 | -3,487 |